CEST theranostics: label-free MR imaging of anticancer drugs

PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia

Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2

Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice

Understanding the role of the kynurenine pathway in human breast cancer immunobiology

Novel strategies to target the ubiquitin proteasome system in multiple myeloma

RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes

SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse

IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study

MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)

ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells

MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation

Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A

HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress

HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun

Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?

NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor

EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target

Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma

Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A

Gene amplification during myogenic differentiation

Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment

Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors

R152C DNA Pol β mutation impairs base excision repair and induces cellular transformation

Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2^V617F-positive myeloproliferative neoplasms

4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway

Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks

Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)

Local 3D matrix confinement determines division axis through cell shape

Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis

Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis

miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells

STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers

Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway

A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers

Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues

A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN)

Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs

DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance

miRNA-29a as a tumor suppressor mediates PRIMA-1^Met-induced anti-myeloma activity by targeting c-Myc

The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer

TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin

DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma

Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer

Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization

A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer

Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs

CXCR2 signaling regulates KRAS^(G12D)-induced autocrine growth of pancreatic cancer

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells

IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer

Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells

Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression

CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and α_vβ₃ integrin clustering

Comparison of liver oncogenic potential among human RAS isoforms